Originally published by our sister publication Infectious Disease Special Edition
When acute bacterial skin and skin structure infections (ABSSSIs) are not cured by oral antibiotics, many health systems opt for inpatient treatment with IV generics. However, these infections treated in the emergency department (ED) with dalbavancin (Dalvance, AbbVie), an antibiotic requiring a single 30-minute infusion, can offer clinically similar and cost-effective results compared with hospital